Myeloid differentiation factor 88-independent Toll-like receptor pathway: Sustaining inflammation or promoting tolerance?

被引:66
作者
Biswas, Subhra K. [1 ]
Tergaonkarl, Vinay
机构
[1] Inst Biomed Sci, Singapore Sci Inst, Singapore 138673, Singapore
[2] ASTAR, Bioinformat Inst, Singapore 138671, Singapore
[3] ASTAR, Inst Mol & Cellular Biol, Singapore 138673, Singapore
关键词
toll-like receptor; MyD88; trif; endotoxin tolerance;
D O I
10.1016/j.biocel.2007.04.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptor signaling represents a principal molecular pathway for host innate immunity. Mechanistically, it can be segregated into two distinct cascades: the myeloid differentiation factor 88-dependent and myeloid differentiation factor 88-independent (or Toll receptor-associated activator of interferon-mediated) cascades. Myeloid differentiation factor 88-dependent signaling is common to all the Toll-like receptors, except Toll-like receptor 3, which exclusively utilizes the myeloid differentiation factor 88-independent pathway. Based on recent evidences, a possible role for myeloid differentiation factor 88-independent pathway not only in sustaining inflammatory responses during Gram-negative infection but also in protective responses like endotoxin tolerance is proposed in this review. We hypothesize that the delayed kinetics of activation of the myeloid differentiation factor 88-independent pathway might be functionally aimed at tuning-down inflammatory reactions through promotion of cellular tolerization and possibly protecting hosts from inflammation-induced injury. Future studies will be needed to experimentally validate this idea and the crucial relevance of the myeloid differentiation factor 88-independent pathway. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1582 / 1592
页数:11
相关论文
共 37 条
  • [1] Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression
    Adib-Conquy, M
    Cavaillon, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) : 27927 - 27934
  • [2] Akashi-Takamura Sachiko, 2006, Journal of Infection and Chemotherapy, V12, P233, DOI 10.1007/s10156-006-0477-4
  • [3] Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1
  • [4] SHIP, TGF-β, and endotoxin tolerance
    Beutler, B
    [J]. IMMUNITY, 2004, 21 (02) : 134 - 135
  • [5] Beutler B, 2002, CURR TOP MICROBIOL, V270, P1
  • [6] Inferences, questions and possibilities in toll-like receptor signalling
    Beutler, B
    [J]. NATURE, 2004, 430 (6996) : 257 - 263
  • [7] A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
    Biswas, SK
    Gangi, L
    Paul, S
    Schioppa, T
    Saccani, A
    Sironi, M
    Bottazzi, B
    Doni, A
    Vincenzo, B
    Pasqualini, F
    Vago, L
    Nebuloni, M
    Mantovani, A
    Sica, A
    [J]. BLOOD, 2006, 107 (05) : 2112 - 2122
  • [8] Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: Relationship to tolerance
    Calvano, JE
    Agnese, DM
    Um, JY
    Goshima, M
    Singhal, R
    Coyle, SM
    Reddell, MT
    Kumar, A
    Calvano, SE
    Lowry, SF
    [J]. SHOCK, 2003, 20 (05): : 415 - 419
  • [9] Endotoxin tolerance: is there a clinical relevance?
    Cavaillon, JM
    Adrie, C
    Fitting, C
    Adib-Conquy, M
    [J]. JOURNAL OF ENDOTOXIN RESEARCH, 2003, 9 (02): : 101 - 107
  • [10] Achieving stability of lipopolysaccharide-induced NF-κB activation
    Covert, MW
    Leung, TH
    Gaston, JE
    Baltimore, D
    [J]. SCIENCE, 2005, 309 (5742) : 1854 - 1857